Colgate-Palmolive Company $CL Shares Bought by Varma Mutual Pension Insurance Co

Varma Mutual Pension Insurance Co grew its position in Colgate-Palmolive Company (NYSE:CLFree Report) by 8.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 185,617 shares of the company’s stock after acquiring an additional 15,200 shares during the quarter. Varma Mutual Pension Insurance Co’s holdings in Colgate-Palmolive were worth $14,838,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in CL. Westside Investment Management Inc. grew its holdings in shares of Colgate-Palmolive by 85.5% during the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after buying an additional 130 shares in the last quarter. Copia Wealth Management purchased a new position in Colgate-Palmolive in the 3rd quarter worth approximately $29,000. Vermillion & White Wealth Management Group LLC grew its position in shares of Colgate-Palmolive by 86.1% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after purchasing an additional 155 shares in the last quarter. Cloud Capital Management LLC acquired a new stake in shares of Colgate-Palmolive in the third quarter valued at approximately $30,000. Finally, MTM Investment Management LLC acquired a new position in Colgate-Palmolive during the second quarter worth $39,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on CL. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Colgate-Palmolive from $83.00 to $90.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. Jefferies Financial Group upped their price objective on Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a report on Monday, February 2nd. TD Cowen reaffirmed a “buy” rating on shares of Colgate-Palmolive in a research note on Monday, February 2nd. Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Wednesday, January 21st. Finally, Raymond James Financial decreased their target price on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a research report on Monday, October 20th. Eleven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus target price of $94.47.

Check Out Our Latest Research Report on Colgate-Palmolive

Colgate-Palmolive Stock Performance

NYSE:CL opened at $96.17 on Friday. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18. The company has a fifty day simple moving average of $83.43 and a two-hundred day simple moving average of $81.83. The company has a quick ratio of 0.27, a current ratio of 0.42 and a debt-to-equity ratio of 5.90. The company has a market cap of $77.52 billion, a price-to-earnings ratio of 36.70, a price-to-earnings-growth ratio of 4.30 and a beta of 0.29.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. During the same quarter in the prior year, the business earned $0.91 EPS. Colgate-Palmolive’s revenue was up 5.8% on a year-over-year basis. As a group, equities analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be paid a dividend of $0.52 per share. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. Colgate-Palmolive’s payout ratio is presently 79.39%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 15,851 shares of Colgate-Palmolive stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the sale, the insider directly owned 13,751 shares of the company’s stock, valued at $1,306,757.53. The trade was a 53.55% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider John Hazlin sold 20,989 shares of the firm’s stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total value of $1,978,213.25. Following the sale, the insider directly owned 17,645 shares in the company, valued at $1,663,041.25. This trade represents a 54.33% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 134,683 shares of company stock valued at $12,708,193 over the last quarter. 0.34% of the stock is owned by insiders.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.